Systematic review of the effects of n-3 fatty acids in inflammatory bowel disease.
暂无分享,去创建一个
W. Mojica | S. Morton | J. Pencharz | S. Rhodes | C. MacLean | S. Newberry | I. Gralnek | P. Khanna | L. Hilton | R. Garland | W. Tu
[1] K. Ewe,et al. N-3 fatty acids only delay early relapse of ulcerative colitis in remission , 1996, Digestive Diseases and Sciences.
[2] A. Hrõbjartsson,et al. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. , 2004, JAMA.
[3] E. Loftus. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. , 2004, Gastroenterology.
[4] M. Fujishima,et al. Serum n3 Polyunsaturated Fatty Acids Are Depleted in Crohn's Disease , 1997, Digestive Diseases and Sciences.
[5] A. Simopoulos,et al. The importance of the ratio of omega-6/omega-3 essential fatty acids. , 2002, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[6] J. Hunter,et al. A double‐blind, randomized, placebo‐controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis , 2002, Alimentary pharmacology & therapeutics.
[7] Robert M. Russell,et al. Present Knowledge in Nutrition , 2001 .
[8] W. Walker,et al. Review: the role of omega 3 fatty acids in intestinal inflammation. , 2001, The Journal of nutritional biochemistry.
[9] B. Toner,et al. Psychosocial aspects of inflammatory bowel disease. , 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[10] O. Eremin,et al. Clinical response of ulcerative colitis with dietary omega-3 fatty acids: a double-blind randomized study , 2000 .
[11] R. Gibson,et al. Dietary polyunsaturated fatty acids and inflammatory mediator production. , 2000, The American journal of clinical nutrition.
[12] L. Friedman,et al. Epidemiology and the natural course of inflammatory bowel disease. , 1999, Gastroenterology clinics of North America.
[13] D. Cook,et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? , 1998, The Lancet.
[14] S. Heys,et al. Distal procto-colitis, natural cytotoxicity, and essential fatty acids , 1998, American Journal of Gastroenterology.
[15] W. Fleig,et al. Omega-3 Fatty Acids and Low Carbohydrate Diet for Maintenance of Remission in Crohn's Disease: A Randomized Controlled Multicenter Trial , 1996 .
[16] M. Campieri,et al. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. , 1996, The New England journal of medicine.
[17] S. Yamato,et al. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. , 1996, The American journal of clinical nutrition.
[18] A R Jadad,et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.
[19] R. Lerman,et al. Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders. , 1996, Metabolism: clinical and experimental.
[20] R. J. Hayes,et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.
[21] C. Ainley,et al. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis , 1993, Alimentary pharmacology & therapeutics.
[22] G. Holmes,et al. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. , 1992, Gut.
[23] T. Gramlich,et al. Dietary Supplementation with Fish Oil in Ulcerative Colitis , 1992, Annals of Internal Medicine.
[24] G. Triadafilopoulos,et al. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. , 1992, The American journal of gastroenterology.
[25] G. Whelan,et al. Epidemiology of inflammatory bowel disease. , 1990, The Medical clinics of North America.
[26] T. Strasser,et al. Supplementation with n‐3 fatty acids from fish oil in chronic inflammatory bowel disease—a randomized, placebo‐controlled, double‐blind cross‐over trial , 1989, Journal of internal medicine. Supplement.
[27] L. Sutherland,et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. , 1987, Gastroenterology.
[28] C. Smith,et al. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. , 1986, Gut.
[29] R. Holman. Control of polyunsaturated acids in tissue lipids. , 1986, Journal of the American College of Nutrition.
[30] N Kromann,et al. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. , 2009, Acta medica Scandinavica.
[31] F Kern,et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. , 1976, Gastroenterology.